A5018544034- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Infective Endocarditis Diagnosis and Management
- Antibiotic Resistance in Bacteria
- Respiratory Support and Mechanisms
- Streptococcal Infections and Treatments
- Pneumonia and Respiratory Infections
- Aortic aneurysm repair treatments
- Urinary Tract Infections Management
- Listeria monocytogenes in Food Safety
- Retinal and Optic Conditions
- Infectious Aortic and Vascular Conditions
- Vascular Procedures and Complications
Saitama Medical University
2022-2025
Saitama International Medical Center
2024-2025
Hidaka Hospital
2023
Background: Severe COVID-19 patients who received ventilator management were not very rare even when the omicron variant became dominant, but clinical characteristics of these are still unclear. Methods: The severe requiring retrospectively investigated from January 2023 to December 2023. Results: accounted for 11 275 (4.2%) during period. Their mean age was 70.7 (51-85) years, and males predominant. Ten eleven (91.7%) managed in emergency department had underlying diseases, including...
Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients MRSA-IE in Japan and identify factors prognosis.
Secondary bacterial infection was initially rare in SARS-CoV-2 infectious disease (COVID-19) patients, but COVID-19-associated diseases have recently been increasing. Furthermore, it might be difficult to distinguish COVID-19 from meningitis by the symptoms, and one uncertain about antibiotic therapy for Listeria infection-typically caused eating contaminated food-in elderly persons pregnant women.A 96-year-old woman who had living alone found February 2023. She admitted our hospital with...
The detailed treatment regimen of COVID-19 patients with hematological malignancies has been unclear, and some fatalities have occurred, although combination therapy antiviral agents corticosteroids established for moderate to severe patients.Case 1 was a 57-year-old woman who had malignant lymphoma received CHOP obinutuzumab, case 2 70-year-old-man myeloma molecular targeted weekly corticosteroid. In both cases, SARS-CoV-2 genes antigens were detected from their nasal swabs, started...
Repeat positive results for SARS-CoV-2 by antigen detection test/RT-PCR in recovered COVID-19 patients were not very rare even when omicron variants became dominant, but the clinical features of with recurrent during hospitalization are still unclear.
Abstract Most humans infected with SARS-CoV-2 will recover without developing pneumonia. A few patients, however, develop pneumonia, and occasionally cytokine storms. In such cases, it is assumed that there an inadequate immune response to eliminate viral cells excessive inappropriate causing organ damage, but little known about this mechanism. study, we used single cell RNA sequencing mass cytometry analyze peripheral blood T from patients hospitalized proven COVID-19 infection in order...